Savchuk Nikolay has filed 15 insider transactions across 1 company since April 2024.
Most recent transaction: a grant/award of 96899 shares of Traws Pharma, Inc. ($TRAW) on March 08, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 8, 2026 | Traws Pharma, Inc. | $TRAW | Savchuk Nikolay | Chief Operating Officer | A | Stock Option (right to buy) | 96899 | $0.00 | 96,899.0000 | 8,818,859 | 9999.99% | 1.10% |
| Dec. 12, 2025 | Traws Pharma, Inc. | $TRAW | Savchuk Nikolay | Chief Operating Officer | A | Common Stock | 16419 | $0.00 | 150,606.0000 | 8,818,859 | 12.24% | 0.19% |
| Dec. 12, 2025 | Traws Pharma, Inc. | $TRAW | Savchuk Nikolay | Chief Operating Officer | A | Stock Option (right to purchase) | 65676 | $0.00 | 65,676.0000 | 8,818,859 | 9999.99% | 0.74% |
| Oct. 12, 2025 | Traws Pharma, Inc. | $TRAW | Savchuk Nikolay | Chief Operating Officer | A | Stock Option (right to purchase) | 22435 | $0.00 | 22,435.0000 | 8,818,859 | 9999.99% | 0.25% |
| Dec. 29, 2024 | Traws Pharma, Inc. | $TRAW | Savchuk Nikolay | Chief Operating Officer | P | Series A Warrant (right to buy) | 96348 | $0.00 | 96,348.0000 | 961,530 | 9999.99% | 10.02% |
| Dec. 29, 2024 | Traws Pharma, Inc. | $TRAW | Savchuk Nikolay | Chief Operating Officer | P | Pre-Funded Warrant (right to buy) | 96348 | $0.00 | 96,348.0000 | 961,530 | 9999.99% | 10.02% |
| April 1, 2024 | Traws Pharma, Inc. | $TRAW | Savchuk Nikolay | Chief Operating Officer | A | Common Stock | 67500 | $0.00 | 134,187.0000 | 841,738 | 101.22% | 8.02% |
| April 1, 2024 | Traws Pharma, Inc. | $TRAW | Savchuk Nikolay | Chief Operating Officer | A | Series C Preferred Stock | 2584 | $0.00 | 7,580.1030 | 841,738 | 51.73% | 0.31% |
| April 1, 2024 | Traws Pharma, Inc. | $TRAW | Savchuk Nikolay | Chief Operating Officer | A | Series C Preferred Stock | 4801 | $0.00 | 7,580.1030 | 841,738 | 172.76% | 0.57% |
| April 1, 2024 | Traws Pharma, Inc. | $TRAW | Savchuk Nikolay | Chief Operating Officer | A | Common Stock | 66687 | $0.00 | 2,597,319.0000 | 841,738 | 2.64% | 7.92% |
| April 1, 2024 | Traws Pharma, Inc. | $TRAW | Savchuk Nikolay | Chief Operating Officer | A | Common Stock | 67550 | $0.00 | 2,664,819.0000 | 841,738 | 2.60% | 8.03% |
| April 1, 2024 | Traws Pharma, Inc. | $TRAW | Savchuk Nikolay | Chief Operating Officer | A | Common Stock | 885532 | $0.00 | 2,664,819.0000 | 841,738 | 49.77% | 100.00% |
| April 1, 2024 | Traws Pharma, Inc. | $TRAW | Savchuk Nikolay | Chief Operating Officer | A | Common Stock | 1645100 | $0.00 | 2,664,819.0000 | 841,738 | 161.33% | 100.00% |
| April 1, 2024 | Traws Pharma, Inc. | $TRAW | Savchuk Nikolay | Chief Operating Officer | A | Stock Option (right to purchase) | 3802890 | $0.00 | 3,802,890.0000 | 841,738 | 9999.99% | 100.00% |
| April 1, 2024 | Traws Pharma, Inc. | $TRAW | Savchuk Nikolay | Chief Operating Officer | A | Series C Preferred Stock | 195 | $0.00 | 7,580.1030 | 841,738 | 2.64% | 0.02% |